Controversial Monsanto Roundup Weed Killer Settlement Under Scrutiny
Fears Nachawati trial lawyers: Settlement asks healthy individuals to make impossible choices about future cancer diagnoses
News provided by
Share this article
Share this article
SAN FRANCISCO, May 19, 2021 /PRNewswire/ -- Lawyers representing thousands of cancer victims exposed to Bayer AG's Roundup weed killer called on a federal judge to reject a proposed settlement that would allow Bayer (OTCMKTS: BAYRY) to continue selling the herbicide while limiting legal options for individuals who are diagnosed with cancer in the future.
The provision allowing Bayer to continue selling Roundup was just one of the controversial details highlighted by objectors to the settlement during a hearing on May 19 before U.S. District Court Judge Vince Chhabria. Among other things, the proposal would require healthy individuals who have already been exposed to Roundup to relinquish their right to sue if they are later diagnosed with non-Hodgkins lymphoma. Similarly, it would limit legal options for those who are exposed to Roundup chemical glyphosate in the future and who later get sick.